Showing 1 to 8 of 8 results
UK Bans Online Ads for Weight Loss Injections
The UK's Advertising Standards Authority (ASA) banned online pharmacies from advertising weight loss injections, such as Wegovy and Mounjaro, in nine new rulings released on [Date], following an investigation into the illegal promotion of prescription-only medications (POMs).
UK Bans Online Ads for Weight Loss Injections
The UK's Advertising Standards Authority (ASA) banned online pharmacies from advertising weight loss injections, such as Wegovy and Mounjaro, in nine new rulings released on [Date], following an investigation into the illegal promotion of prescription-only medications (POMs).
Progress
44% Bias Score
Weight Regain After Stopping Weight-Loss Injections: An Oxford Study
A University of Oxford study reveals that individuals using weight-loss injections regain a significant portion of lost weight within 10 months of stopping treatment, regardless of the injection type; newer, more effective drugs lead to greater weight loss but also greater weight regain.
Weight Regain After Stopping Weight-Loss Injections: An Oxford Study
A University of Oxford study reveals that individuals using weight-loss injections regain a significant portion of lost weight within 10 months of stopping treatment, regardless of the injection type; newer, more effective drugs lead to greater weight loss but also greater weight regain.
Progress
48% Bias Score
Weight Loss Injections: Pharmacy Access Planned
A potential multimillion-pound deal could allow pharmacies in England to offer weight loss injections like Ozempic and Wegovy for £9.90 after a short consultation, addressing current NHS limitations and long wait times.
Weight Loss Injections: Pharmacy Access Planned
A potential multimillion-pound deal could allow pharmacies in England to offer weight loss injections like Ozempic and Wegovy for £9.90 after a short consultation, addressing current NHS limitations and long wait times.
Progress
44% Bias Score
Weight-Loss Injections: Large Study Shows Significant Health Benefits, Rare Risks
A study of nearly two million veterans with type-2 diabetes found that GLP-1 receptor agonists (like Ozempic and Wegovy) significantly reduced risks of heart disease, stroke, neurodegenerative diseases, and mental health issues, despite some rare but serious side effects like pancreatitis and kidney...
Weight-Loss Injections: Large Study Shows Significant Health Benefits, Rare Risks
A study of nearly two million veterans with type-2 diabetes found that GLP-1 receptor agonists (like Ozempic and Wegovy) significantly reduced risks of heart disease, stroke, neurodegenerative diseases, and mental health issues, despite some rare but serious side effects like pancreatitis and kidney...
Progress
40% Bias Score
Weight-Loss Injections Pose Contraceptive Risks: Urgent MHRA Warning
The UK's MHRA issued an urgent warning that weight-loss injections, including Ozempic, Wegovy, and Mounjaro, may reduce contraceptive effectiveness and pose risks to pregnant women and fetuses, prompting advice on birth control and immediate cessation upon pregnancy.
Weight-Loss Injections Pose Contraceptive Risks: Urgent MHRA Warning
The UK's MHRA issued an urgent warning that weight-loss injections, including Ozempic, Wegovy, and Mounjaro, may reduce contraceptive effectiveness and pose risks to pregnant women and fetuses, prompting advice on birth control and immediate cessation upon pregnancy.
Progress
60% Bias Score
Weight Loss Injections' Rise Contributes to Weight Watchers' Bankruptcy
Simon, 34, lost 26 kg using Monjaro weight loss injections after years of failed dieting, including with Weight Watchers which has lost over a million members and filed for bankruptcy amid the rise of weight loss injections and social media.
Weight Loss Injections' Rise Contributes to Weight Watchers' Bankruptcy
Simon, 34, lost 26 kg using Monjaro weight loss injections after years of failed dieting, including with Weight Watchers which has lost over a million members and filed for bankruptcy amid the rise of weight loss injections and social media.
Progress
56% Bias Score
Weight-Loss Injections Linked to Increased Gallbladder Surgery Risk
Pharmacist Deborah Grayson warns of a rise in gallbladder surgeries among patients using weight-loss injections like Mounjaro, attributing the increased risk of gallstones to the drug's mechanism of slowing bile flow; this affects up to 10 percent of users, necessitating greater patient awareness an...
Weight-Loss Injections Linked to Increased Gallbladder Surgery Risk
Pharmacist Deborah Grayson warns of a rise in gallbladder surgeries among patients using weight-loss injections like Mounjaro, attributing the increased risk of gallstones to the drug's mechanism of slowing bile flow; this affects up to 10 percent of users, necessitating greater patient awareness an...
Progress
52% Bias Score
Weight-Loss Injections Strain UK NHS
Two injectable weight-loss medications, Wegovy and Mounjaro, are showing efficacy in the UK, but concerns exist regarding increased demand on the NHS, limited availability, and private market costs ranging from £200-£300 per pen.
Weight-Loss Injections Strain UK NHS
Two injectable weight-loss medications, Wegovy and Mounjaro, are showing efficacy in the UK, but concerns exist regarding increased demand on the NHS, limited availability, and private market costs ranging from £200-£300 per pen.
Progress
20% Bias Score
Showing 1 to 8 of 8 results